Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023878

CHIEF OPERATING OFFICER sold 98,660 shares at an average $35.54 ($3,506,278)

  • CHIEF OPERATING OFFICER acquired 98,660 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-09-04 Option exercise 10b5-1 +38,725 $15.50 $600,238 83,177 D
Tessari Eben CHIEF OPERATING OFFICER 2025-09-04 Option exercise 10b5-1 +46,546 $15.52 $722,394 129,723 D
Tessari Eben CHIEF OPERATING OFFICER 2025-09-04 Sale 10b5-1 −85,271 $35.52 $3,028,826 44,452 D
Tessari Eben CHIEF OPERATING OFFICER 2025-09-05 Option exercise 10b5-1 +13,389 $15.52 $207,797 57,841 D
Tessari Eben CHIEF OPERATING OFFICER 2025-09-05 Sale 10b5-1 −13,389 $35.66 $477,452 44,452 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2025-09-04 Option exercise · Share Option 10b5-1 −38,725 6,249 D
Tessari Eben CHIEF OPERATING OFFICER 2025-09-04 Option exercise · Share Option 10b5-1 −46,546 13,389 D
Tessari Eben CHIEF OPERATING OFFICER 2025-09-05 Option exercise · Share Option 10b5-1 −13,389 0 D
Open-market sales · 98,660 sh · avg $35.54 · $3,506,278
Loading xslF345X05/form4-09082025_080944.xml…